Dai Ichi Life Insurance Company, LTD Novavax Inc Transaction History

Dai Ichi Life Insurance Company, LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $259,883 - $532,588	-3,727 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $8,073 - $13,078	60 Added 1.64%	3,727 $533,000
Q3 2021 Nov 04, 2021	BUY	$177.8 - $270.58 $651,992 - $992,216	3,667 New	3,667 $760,000

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.